This backbone of the U.S. health-care industry generates about 99% of its revenue domestically, insulating it from overseas pressure.
Get this delivered to your inbox, and more info about our products and services.
The stock's drop this week isn't tied to fundamentals.
Josh Brown and Sean Russo break down this stock that could be ready to rip higher.
We're making our third sale of this health-care stock since its earnings sell-off.
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of…
Frank Holland breaks down what traders are watching ahead of the new session.
The investment bank upgraded the pharma stock to overweight from equal weight.
